AutoGenomics (AGMX) Files $86.3M IPO
Tweet Send to a Friend
AutoGenomics, Inc. (Nasdaq: AGMX) filed a registration statement with the SEC for an initial public offering of its common stock. The proposed maximum aggregate offering price is $86.3 million. The company plans to list on the NASDAQ under the stock symbol "AGMX."
The offering is being made through Jefferies, Baird and Thomas Weisel.
AutoGenomics designs, develops, manufactures and markets a fully integrated molecular diagnostics platform called the INFINITI system that includes its highly automated bench-top INFINITI Analyzer, which has the versatility to run a large menu of genetic tests.
The offering is being made through Jefferies, Baird and Thomas Weisel.
AutoGenomics designs, develops, manufactures and markets a fully integrated molecular diagnostics platform called the INFINITI system that includes its highly automated bench-top INFINITI Analyzer, which has the versatility to run a large menu of genetic tests.
You May Also Be Interested In
- Dan Loeb Builds Massive Stake in Sony (SNE), Wants Entertainment Arm Split
- Ambit Biosciences (AMBI) IPO Opens Flat
- Tableau Software (DATA) IPO indicated $37-$40 after pricing at $31
Create E-mail Alert Related Categories
IPOsRelated Entities
Jefferies & Co, Robert W Baird, Thomas Weisel Partners Group
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
